No Data
No Data
China Securities Co., Ltd. expects that the "expanding domestic demand" trade will gradually grow, covering cyclical and growth stocks.
China Securities Co.,Ltd. released a research report stating that it is expected that the 'expanding domestic demand' trade will gradually grow, covering both cyclical and growth stocks.
Henlius Biotech Merger Delay Announcement
Fosun Pharma Receives Offers for Share Alternative Offer Related to Henlius Merger Offer
Henlius (02696.HK) received shareholding of 1.1125 million shares from shareholder Lin Lijun.
According to the latest equity disclosure information from the Stock Exchange, on July 10, 2024, Henlius (02696.HK) shareholder Lin Lijun increased his shareholding by 1.1125 million shares at an average price of HKD 22.8237 per share, involving about HKD 25.3914 million. After the increase, Lin Lijun's latest holdings were 9.1557 million shares, and the shareholding ratio increased from 4.92% to 5.60%.
Henlius Biotech Advances Towards Privatization
Shanghai Henlius Biotech Gets the Nod From Japan's PMDA for Japan Trials
No Data